Alan has more than 20 years of experience advising startups on their journey of growth into world-class public companies. Focusing on the technology, biotechnology and medical devices sectors, Alan guides clients through critical junctures in their lifecycle, from obtaining initial funding to raising follow-on capital and evaluating exit opportunities.
Notable recent examples include cloud-based software company Smartsheet, which Alan advised from formation to its public offering, and real estate site Redfin, which Alan assisted from Series A to IPO.
Recognized as one of the nation’s leading lawyers for corporate, M&A, capital markets, securities and venture capital, Alan also assists companies with regulatory compliance, employee relations and governance requirements. He serves as chair of Fenwick’s corporate group.
Alan dives deep into a range of technologies, including e-commerce, hardware, software/SaaS and cloud computing, robotics, mobile and wireless, data storage and consumer products.
He also represents biotech companies developing therapeutics for oncology, immunological, neurological and other indications, and medical device companies pursuing cardiac, neurological and surgical indications, and diagnostics and drug delivery devices.
With strong ties to both the venture community and emerging companies, Alan’s most rewarding career moments involve connecting innovative entrepreneurs with interested investors and helping their startups grow into established companies that revolutionize technologies and industries.
Clients rely on Alan for thoughtful, strategic and practical advice that takes into account both business and legal challenges. He focuses his attention on the entire business—from the concept, founders, investors and board of directors to the marketing strategy and the company’s relationship with important partners and vendors.
He is recognized as among the top practitioners in his field:
- Top corporate, capital markets, and mergers and acquisitions lawyer in Washington State, Chambers USA (annually since 2008)
- Washington Super Lawyer (annually since 2003)
- Top capital markets and fintech lawyer, The Legal 500 (2019). Has also been highlighted as a leading M&A and technology transactions lawyer by The Legal 500.
- Among the best lawyers in America for corporate law, venture capital, M&A and securities/capital markets, U.S. News & World Report’s Best Lawyers Guide (2018)
- Top tech lawyer, Greater Seattle Tech Ecosystem Report by the Iinnovate Leadership Network and the University of Washington Bothell (2018)
Alan is frequently sought as a speaker on a wide range of corporate finance topics, including the initial public offering process, venture capital and angel financing, and mergers and acquisitions.
Another of Alan’s passions is mountaineering; he is currently pursuing a goal to climb all 20 Cascade Volcanoes (and ski down most of them). When not scaling and skiing the peaks, Alan also enjoys ski racing, cycling, ice hockey, waterskiing, wakesurfing and spending time outdoors in the Pacific Northwest with his family.
- Represented Cray, a global leader in supercomputing, in its $1.3B acquisition by Hewlett Packard Enterprise and the $140M sale of Cray’s interconnect hardware development program to Intel and its approximately $22M acquisition of Appro International.
- Represented Redfin, a customer-first real estate brokerage, in its initial public offering, its $70.9M venture financing and its acquisition of Walk Score. Currently providing ongoing counseling to the company.
- Represented buuteeq, one of the leading digital marketing platforms for hotels, in its acquisition by The Priceline Group, and its previous $10M Series B financing round.
- Represented Smartsheet, a leading SaaS company, in its $175M initial public offering, its $52M Series F financing and in previous financing rounds. Currently providing ongoing counseling to the company.
- Represented Act-On Software, a leading marketing automation provider for small and mid-market enterprises, in its $42M venture financing. Currently providing ongoing counseling to the company.
- Represented OncoGenex Pharmaceuticals, a biopharmaceutical company developing new cancer therapies, in its merge with Achieve Life Science and its $50M public stock offering. Currently providing ongoing counseling to the company.
- Represented Qumulo, an enterprise data storage company, in its most recent $30M Series C prime financing and in previous financing rounds. Currently providing ongoing counseling to the company.
- Represented Cascadian Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing innovative product candidates for the treatment of cancer, in its $41.8M concurrent at-the-market offerings of common stock and Series D convertible preferred stock.
- Represented Trupanion, a provider of pet medical insurance, in its initial public offering. Currently providing ongoing counseling to the company.
- Represented Swype, a software provider that makes it easier to keyboard information on touch screens, in its $100M acquisition by Nuance Technologies.
- Represented Accelecare, a national wound treatment center operator, in its $70M private equity financing and its recent acquisition by Healogics.
- Represented leading venture capital firms in strategic investments including Draper Fisher Jurvetson, Clarus Ventures, JAZZ Venture Partners, Madrona Ventures, Trinity Ventures and Voyager Capital.
- Represented both issuers and underwriters on numerous IPOs and other public offerings, including offerings by Boeing, Corixa, Immunex, Icos, ImageX, OncoGenex, Cascadian Therapeutics, Onyx Software, SonoSite, Targeted Genetics, ShopNow.com, Trubion, Trupanion, WatchGuard Technologies and Zillow.